This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ngm Biopharmaceuticals, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Julie Michelle Roda: Innovator in ILT3-Binding Agents
Introduction
Julie Michelle Roda is a prominent inventor based in Pacifica, CA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of ILT3-binding agents. With a total of 2 patents to her name, her work is paving the way for advancements in therapeutic applications.
Latest Patents
Roda's latest patents focus on ILT3-binding agents and methods of use thereof. The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3. Additionally, it includes compositions comprising the binding agents and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
Career Highlights
Julie Roda is currently employed at NGM Biopharmaceuticals, Inc., where she continues to innovate and contribute to the field. Her expertise in biopharmaceuticals has positioned her as a key player in the development of new therapeutic agents.
Collaborations
Some of her notable coworkers include Suzanne Christine Crawley and Jer-Yuan Hsu. Their collaborative efforts enhance the research and development initiatives at NGM Biopharmaceuticals.
Conclusion
Julie Michelle Roda is a distinguished inventor whose work on ILT3-binding agents is making a significant impact in the biopharmaceutical industry. Her contributions are essential for the advancement of therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
